MacroGenics
MGNX
#8794
Rank
ยฃ0.18 B
Marketcap
ยฃ2.83
Share price
5.35%
Change (1 day)
115.67%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : ยฃ0.22 Billion

According to MacroGenics's latest financial reports the company's total liabilities are ยฃ0.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ0.14 B28.8%
2024-12-31ยฃ0.11 B1.38%
2023-12-31ยฃ0.11 B0%
2022-12-31ยฃ0.11 B61.55%
2021-12-31ยฃ70.84 M16.54%
2020-12-31ยฃ60.78 M-2.64%
2019-12-31ยฃ62.43 M-11.2%
2018-12-31ยฃ70.31 M27.31%
2017-12-31ยฃ55.23 M60.31%
2016-12-31ยฃ34.45 M11.16%
2015-12-31ยฃ30.99 M-8.26%
2014-12-31ยฃ33.78 M18.91%
2013-12-31ยฃ28.41 M-25.91%
2012-12-31ยฃ38.34 M-25.65%
2011-12-31ยฃ51.57 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
ยฃ87.38 B 38,123.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ81.91 B 35,731.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ63.44 B 27,649.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ28.42 B 12,334.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ66.36 B 28,927.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ49.35 B 21,489.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
ยฃ0.16 B-26.71%๐Ÿ‡บ๐Ÿ‡ธ USA